Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Mar;105(3):667–674. doi: 10.1111/j.1476-5381.1992.tb09036.x

Characterization of histamine-H3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea-pig isolated ileum.

S J Taylor 1, G J Kilpatrick 1
PMCID: PMC1908443  PMID: 1352720

Abstract

1. In the presence of atropine, mepyramine and ranitidine, electric field stimulation of the guinea-pig isolated ileum longitudinal muscle-myenteric plexus preparation resulted in a two component non-adrenergic non-cholinergic contraction. The initial contraction had a duration of approximately 1 s whereas the second contraction lasted approximately 10 s. The second contraction was completely inhibited by tetrodotoxin (0.2 x 10(-6) M) with minimal effect on the initial contraction. Phentolamine (3 x 10(-6) M), propranolol (3 x 10(-6) M) and hexamethonium (10(-4) M), did not significantly reduce either component of the contractile response. 2. The neurokinin NK1 receptor antagonists, GR82334 and GR71251, produced concentration-related (EC50 = 564 and 173 nM respectively) inhibitions of the second contraction with no effect on the initial contraction. The neurokinin NK2 receptor antagonists MEN 10207 and Ac-Leu-Asp-Gln-Trp-Phe-Gly-NH2 (R 396), 1 x 10(-9)-10(-5) M, were without effect on either component of the contractile response. 3. Concentration-related inhibitions of the second contraction, with no effect on the initial contraction, were observed after inclusion of the histamine H3 receptor agonists (R)-alpha-methylhistamine (pD2 = 7.6), N alpha-methylhistamine (pD2 = 7.7) and N alpha,N alpha-dimethylhistamine (pD2 = 6.3). Histamine also inhibited the second contraction (pD2 = 6.2) in a concentration-related manner but produced a lower maximum inhibitory effect than the other agonists tested. 4. Inclusion of the H3 receptor antagonists, thioperamide, burimamide, impromidine and phenylbutanoylhistamine, caused parallel concentration-related rightward shifts in the concentration-response curve to (R)-alpha-methylhistamine.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
671

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambache N., Freeman M. A. Atropine-resistant longitudinal muscle spasms due to excitation of non-cholinergic neurones in Auerbach's plexus. J Physiol. 1968 Dec;199(3):705–727. doi: 10.1113/jphysiol.1968.sp008674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ambache N., Killick S. W., Zar M. A. Antagonism by burimamide of inhibitions induced by histamine in plexus-containing longitudinal muscle preparations from guinea-pig ileum. Br J Pharmacol. 1973 Jun;48(2):362P–363P. [PMC free article] [PubMed] [Google Scholar]
  3. Ambache N., Zar M. A. An inhibitory action of histamine on the guinea-pig ileum. Br J Pharmacol. 1970 Jan;38(1):229–240. doi: 10.1111/j.1476-5381.1970.tb10352.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arrang J. M., Garbarg M., Lancelot J. C., Lecomte J. M., Pollard H., Robba M., Schunack W., Schwartz J. C. Highly potent and selective ligands for histamine H3-receptors. Nature. 1987 May 14;327(6118):117–123. doi: 10.1038/327117a0. [DOI] [PubMed] [Google Scholar]
  5. Arrang J. M., Garbarg M., Quach T. T., Dam Trung TuongM, Yeramian E., Schwartz J. C. Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol. 1985 Apr 23;111(1):73–84. doi: 10.1016/0014-2999(85)90115-3. [DOI] [PubMed] [Google Scholar]
  6. Arrang J. M., Garbarg M., Schwartz J. C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature. 1983 Apr 28;302(5911):832–837. doi: 10.1038/302832a0. [DOI] [PubMed] [Google Scholar]
  7. Ash A. S., Schild H. O. Receptors mediating some actions of histamine. Br J Pharmacol Chemother. 1966 Aug;27(2):427–439. doi: 10.1111/j.1476-5381.1966.tb01674.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Battaglia G., Norman A. B., Newton P. L., Creese I. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery. J Neurochem. 1986 Feb;46(2):589–593. doi: 10.1111/j.1471-4159.1986.tb13008.x. [DOI] [PubMed] [Google Scholar]
  9. Belleau B., DiTullio V., Godin D. The mechanism of irreversible adrenergic blockade by N-carbethoxydihydroquinolines--model studies with typical serine hydrolases. Biochem Pharmacol. 1969 May;18(5):1039–1044. doi: 10.1016/0006-2952(69)90107-5. [DOI] [PubMed] [Google Scholar]
  10. Belleau B., Martel R., Lacasse G., Ménard M., Weinberg N. L., Perron Y. G. N-carboxylic acid esters of 1,2- and 1,4-dihydroquinolines. A new class of irreversible inactivators of the catecholamine alpha receptors and potent central nervous system depressants. J Am Chem Soc. 1968 Jan 31;90(3):823–824. doi: 10.1021/ja01005a067. [DOI] [PubMed] [Google Scholar]
  11. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  12. Demolle D., Boeynaems J. M. Cholera and pertussis toxins amplify prostacyclin synthesis in aortic smooth muscle cells. Br J Pharmacol. 1989 Nov;98(3):717–720. doi: 10.1111/j.1476-5381.1989.tb14597.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fjalland B. Evidence for the existence of another type of histamine H2-receptor in guinea-pig ileum. J Pharm Pharmacol. 1979 Jan;31(1):50–51. doi: 10.1111/j.2042-7158.1979.tb13423.x. [DOI] [PubMed] [Google Scholar]
  14. Hamblin M. W., Creese I. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Life Sci. 1983 May 9;32(19):2247–2255. doi: 10.1016/0024-3205(83)90423-x. [DOI] [PubMed] [Google Scholar]
  15. Hew R. W., Hodgkinson C. R., Hill S. J. Characterization of histamine H3-receptors in guinea-pig ileum with H3-selective ligands. Br J Pharmacol. 1990 Nov;101(3):621–624. doi: 10.1111/j.1476-5381.1990.tb14130.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ichinose M., Barnes P. J. Histamine H3-receptors modulate nonadrenergic noncholinergic neural bronchoconstriction in guinea-pig in vivo. Eur J Pharmacol. 1989 Dec 12;174(1):49–55. doi: 10.1016/0014-2999(89)90872-8. [DOI] [PubMed] [Google Scholar]
  17. Ichinose M., Stretton C. D., Schwartz J. C., Barnes P. J. Histamine H3-receptors inhibit cholinergic neurotransmission in guinea-pig airways. Br J Pharmacol. 1989 May;97(1):13–15. doi: 10.1111/j.1476-5381.1989.tb11917.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kilpatrick G. J., Michel A. D. Characterisation of the binding of the histamine H3 receptor agonist [3H] (R)-alpha methyl histamine to homogenates of rat and guinea-pig cortex. Agents Actions Suppl. 1991;33:69–75. doi: 10.1007/978-3-0348-7309-3_4. [DOI] [PubMed] [Google Scholar]
  19. Leff P. Analysis of agonist action using the operational model. Trends Pharmacol Sci. 1988 Nov;9(11):395–398. doi: 10.1016/0165-6147(88)90065-x. [DOI] [PubMed] [Google Scholar]
  20. Leff P., Dougall I. G., Harper D. H., Dainty I. A. Errors in agonist affinity estimation: do they and should they occur in isolated tissue experiments? Trends Pharmacol Sci. 1990 Feb;11(2):64–67. doi: 10.1016/0165-6147(90)90319-4. [DOI] [PubMed] [Google Scholar]
  21. Leurs R., Brozius M. M., Smit M. J., Bast A., Timmerman H. Effects of histamine H1-, H2- and H3-receptor selective drugs on the mechanical activity of guinea-pig small and large intestine. Br J Pharmacol. 1991 Jan;102(1):179–185. doi: 10.1111/j.1476-5381.1991.tb12150.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Maggi C. A., Patacchini R., Giuliani S., Rovero P., Dion S., Regoli D., Giachetti A., Meli A. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes. Br J Pharmacol. 1990 Jul;100(3):589–592. doi: 10.1111/j.1476-5381.1990.tb15851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. McPherson G. A., Molenaar P., Raper C., Malta E. Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted nonlinear curve fitting program. J Pharmacol Methods. 1983 Dec;10(4):231–241. doi: 10.1016/0160-5402(83)90017-7. [DOI] [PubMed] [Google Scholar]
  24. Menkveld G. J., Timmerman H. Inhibition of electrically evoked contractions of guinea-pig ileum preparations mediated by the histamine H3 receptor. Eur J Pharmacol. 1990 Sep 21;186(2-3):343–347. doi: 10.1016/0014-2999(90)90458-i. [DOI] [PubMed] [Google Scholar]
  25. RANG H. P. STIMULANT ACTIONS OF VOLATILE ANAESTHETICS ON SMOOTH MUSCLE. Br J Pharmacol Chemother. 1964 Apr;22:356–365. doi: 10.1111/j.1476-5381.1964.tb02040.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schlicker E., Betz R., Göthert M. Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol. 1988 May;337(5):588–590. doi: 10.1007/BF00182737. [DOI] [PubMed] [Google Scholar]
  27. Schlicker E., Fink K., Hinterthaner M., Göthert M. Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):633–638. doi: 10.1007/BF00717738. [DOI] [PubMed] [Google Scholar]
  28. Timmerman H. Histamine H3 ligands: just pharmacological tools or potential therapeutic agents? J Med Chem. 1990 Jan;33(1):4–11. doi: 10.1021/jm00163a001. [DOI] [PubMed] [Google Scholar]
  29. Trzeciakowski J. P. Inhibition of guinea pig ileum contractions mediated by a class of histamine receptor resembling the H3 subtype. J Pharmacol Exp Ther. 1987 Dec;243(3):874–880. [PubMed] [Google Scholar]
  30. West R. E., Jr, Zweig A., Granzow R. T., Siegel M. I., Egan R. W. Biexponential kinetics of (R)-alpha-[3H]methylhistamine binding to the rat brain H3 histamine receptor. J Neurochem. 1990 Nov;55(5):1612–1616. doi: 10.1111/j.1471-4159.1990.tb04946.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES